Cargando…
Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives
Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players involved in lymphomagenesis, and the identification of new diagnostic and prognostic biomarkers is urgent. MicroRNAs and long non-coding RNAs em...
Autores principales: | Fernandes, Mara, Marques, Herlander, Teixeira, Ana Luísa, Medeiros, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698845/ https://www.ncbi.nlm.nih.gov/pubmed/34944752 http://dx.doi.org/10.3390/biomedicines9121934 |
Ejemplares similares
-
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine
por: Fernandes, Mara, et al.
Publicado: (2021) -
ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort
por: Fernandes, Mara, et al.
Publicado: (2021) -
Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study
por: Fernandes, Mara, et al.
Publicado: (2022) -
Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
por: Qin, Shuang, et al.
Publicado: (2023) -
Reconstruction and analysis of the aberrant lncRNA‐miRNA‐mRNA network based on competitive endogenous RNA in CESC
por: Song, Jukun, et al.
Publicado: (2018)